Purchase Order HHSN267200800319P

This is a firm fixed price BPA call award to Roche Diagnostics Corporation, valued at $89,056.86, to provide COBAS E-ELEC PROBNP II STAT # 5390109160 to the Defense Health Agency. The award is not associated with a set-aside program. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The company has received numerous federal contract awards to supply medical equipment and consumables...

The U.S. Department of Veterans Affairs awarded a Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of GENMARK EPLEX reagents and maintenance services for the Veterans Integrated Service Network 19 (VISN 19). The contract has a ceiling value of $953,954.00 and an ultimate completion date of December 29, 2025. This is a firm fixed-price contract with no set-aside designation. Roche Diagnostics is a manufacturer...

This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 (VISN 19) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for $5,009,874.71. The contract is for the provision of GENMARK EPLEX reagents and maintenance services to support the VA's laboratory testing capabilities. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory...

Roche Diagnostics Corporation was awarded a $115,060.85 firm fixed price blanket purchase agreement (BPA) call by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19. The BPA call, titled "BPA CALL YR4, PT/INR Assays BPA for Aurora VA, Oklahoma City VA and Salt Lake City VA," has a completion date of September 9, 2023 and was awarded on September 10, 2022. The contract has no set-aside designation and will provide prothrombin...

This is a BPA (Blanket Purchase Agreement) call awarded by the Air Force Materiel Command to Roche Diagnostics Corporation to provide cost-per-test immunochemistry services and related laboratory supplies. The award has a ceiling value of $97,027.81 and an ultimate completion date of February 14, 2018. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, and has held multiple government contracts to provide medical devices, instruments,...

This contract award to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, is for the delivery of LIGHTCYLER URACIL-DNA glycosylase and DNTP BLEND products to the Department of the Navy Bureau of Medicine and Surgery. The $248,190.00 firm fixed price purchase order was awarded on July 20, 2021 with a completion date of August 6, 2021. No set-aside was used for this award. Roche Diagnostics is an established federal contractor, holding multiple General Services...

Roche Diagnostics Corporation was awarded a firm fixed price blanket purchase agreement (BPA) call by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19. The BPA call is for influenza testing services with a potential value of $159,621. The period of performance is from October 1, 2022 through September 30, 2023 with all work to be performed in Oklahoma City, Oklahoma. This BPA call was issued under Roche's existing BPA with the VA to provide...

This federal contract award is for "IHC/ISH COST PER TEST DELIVERY ORDER" to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22, with a completion date of April 8, 2020 and an award date of August 25, 2017. The contract is a Blanket Purchase Agreement (BPA) Call with a firm fixed price pricing type, and has a potential value of...

<p>Rokabio Inc., doing business as Roka Bioscience, has been awarded a $195,505 firm fixed price purchase order by the Defense Health Agency to deliver the PRT-1398 EG2COMBO STEC assay. The contract has no set-aside designation and requires completion of the assay by September 30, 2023. Roka Bioscience will perform the contract from its location in Fort Sam Houston, Texas to support the Defense Health Agency's medical product needs. No major subcontractors were identified.</p>

This is a Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract is for REAGENTS AND SUPPLIES with a ceiling value of $59,787.69 and an ultimate completion date of September 30, 2019. This BPA call is part of a larger $37 million BPA with DHA for immunochemistry and clinical...